132 related articles for article (PubMed ID: 38829246)
1. [Vanishing white matter disease, a rare leukodystrophy with mutation in the EIF2B5 gene].
Sinkó G; Tompa M; Kiss Z; Kálmán B
Ideggyogy Sz; 2024 May; 77(5-6):207-211. PubMed ID: 38829246
[TBL] [Abstract][Full Text] [Related]
2. Adult-onset vanishing white matter disease with the EIF2B2 gene mutation presenting as menometrorrhagia.
Wei C; Qin Q; Chen F; Zhou A; Wang F; Zuo X; Chen R; Lyu J; Jia J
BMC Neurol; 2019 Aug; 19(1):203. PubMed ID: 31438897
[TBL] [Abstract][Full Text] [Related]
3. An eleven-year history of Vanishing White Matter Disease in an adult patient with no cognitive decline and
Trevisan L; Grazzini M; Cianflone A; Accogli A; Finocchi C; Capello E; Saitta L; Grandis M; Roccatagliata L; Mandich P
Neurocase; 2021 Dec; 27(6):452-456. PubMed ID: 34751098
[TBL] [Abstract][Full Text] [Related]
4. A Japanese girl with an early-infantile onset vanishing white matter disease resembling Cree leukoencephalopathy.
Takano K; Tsuyusaki Y; Sato M; Takagi M; Anzai R; Okuda M; Iai M; Yamashita S; Okabe T; Aida N; Tsurusaki Y; Saitsu H; Matsumoto N; Osaka H
Brain Dev; 2015 Jun; 37(6):638-42. PubMed ID: 25457085
[TBL] [Abstract][Full Text] [Related]
5. [Association between homozygous c.318A>GT mutation in exon 2 of the EIF2B5 gene and the infantile form of vanishing white matter leukoencephalopathy].
Esmer C; Blanco Hernández G; Saavedra Alanís V; Reyes Vaca JG; Bravo Oro A
Bol Med Hosp Infant Mex; 2017; 74(5):364-369. PubMed ID: 29382480
[TBL] [Abstract][Full Text] [Related]
6. Glial pathology in a novel spontaneous mutant mouse of the Eif2b5 gene: a vanishing white matter disease model.
Terumitsu-Tsujita M; Kitaura H; Miura I; Kiyama Y; Goto F; Muraki Y; Ominato S; Hara N; Simankova A; Bizen N; Kashiwagi K; Ito T; Toyoshima Y; Kakita A; Manabe T; Wakana S; Takebayashi H; Igarashi H
J Neurochem; 2020 Jul; 154(1):25-40. PubMed ID: 31587290
[TBL] [Abstract][Full Text] [Related]
7. Adult Vanishing White Matter Disease with a Novel EIF2B4 Mutation.
Su T; Yuan H; Gao W; Li H; Yuan M
J Coll Physicians Surg Pak; 2022 Dec; 32(12):SS181-SS183. PubMed ID: 36597332
[TBL] [Abstract][Full Text] [Related]
8. Juxtacortical White Matter Hypointensity on T2*Gradient Echo Image in Vanishing White Matter Disease: A Case Report.
Lim CG; Hahm MH; Lee HJ
Am J Case Rep; 2023 Feb; 24():e938569. PubMed ID: 36793200
[TBL] [Abstract][Full Text] [Related]
9. In vivo base editing of a pathogenic Eif2b5 variant improves vanishing white matter phenotypes in mice.
Böck D; Revers IM; Bomhof ASJ; Hillen AEJ; Boeijink C; Kissling L; Egli S; Moreno-Mateos MA; van der Knaap MS; van Til NP; Schwank G
Mol Ther; 2024 May; 32(5):1328-1343. PubMed ID: 38454603
[TBL] [Abstract][Full Text] [Related]
10. Vanishing white matter disease with mutations in EIF2B5 gene.
Sharma S; Ajij M; Singh V; Aneja S
Indian J Pediatr; 2015 Jan; 82(1):93-5. PubMed ID: 25230711
[TBL] [Abstract][Full Text] [Related]
11. Identification of a Missense Variant in the EIF2B3 Gene Causing Vanishing White Matter Disease with Antenatal-Onset but Mild Symptoms and Long-Term Survival.
Khorrami M; Khorram E; Yaghini O; Rezaei M; Hejazifar A; Iravani O; Yazdani V; Riahinezhad M; Kheirollahi M
J Mol Neurosci; 2021 Nov; 71(11):2405-2414. PubMed ID: 33687620
[TBL] [Abstract][Full Text] [Related]
12. [Spasticity and progressive ataxia due to vanishing white matter].
Paez-Granda D; Jimenez-Sanchez A; Fernandez-Hernandez C; Serrano-Garcia C
Rev Neurol; 2017 Dec; 65(12):563-564. PubMed ID: 29235619
[TBL] [Abstract][Full Text] [Related]
13. Adult-onset leukodystrophy with vanishing white matter: a case series of 19 patients.
Benzoni C; Moscatelli M; Farina L; Magri S; Ciano C; Scaioli V; Alverà S; Cammarata G; Bianchi-Marzoli S; Castellani M; Zito FM; Marotta G; Piacentini S; Villacara A; Mantegazza R; Gellera C; Durães J; Gouveia A; Matos A; do Carmo Macário M; Pareyson D; Taroni F; Di Bella D; Salsano E
J Neurol; 2023 Sep; 270(9):4219-4234. PubMed ID: 37171481
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the genes encoding eukaryotic translation initiation factor 2B in Japanese patients with vanishing white matter disease.
Shimada S; Shimojima K; Sangu N; Hoshino A; Hachiya Y; Ohto T; Hashi Y; Nishida K; Mitani M; Kinjo S; Tsurusaki Y; Matsumoto N; Morimoto M; Yamamoto T
Brain Dev; 2015 Nov; 37(10):960-6. PubMed ID: 25843247
[TBL] [Abstract][Full Text] [Related]
15. Affected astrocytes in the spinal cord of the leukodystrophy vanishing white matter.
Leferink PS; Breeuwsma N; Bugiani M; van der Knaap MS; Heine VM
Glia; 2018 Apr; 66(4):862-873. PubMed ID: 29285798
[TBL] [Abstract][Full Text] [Related]
16. Ovarioleukodystrophy due to EIF2B5 mutations.
Ibitoye RT; Renowden SA; Faulkner HJ; Scolding NJ; Rice CM
Pract Neurol; 2016 Dec; 16(6):496-499. PubMed ID: 27651498
[TBL] [Abstract][Full Text] [Related]
17. EIF2B2 gene mutation causing early onset vanishing white matter disease: a case report.
Filareto I; Cinelli G; Scalabrini I; Caramaschi E; Bergonzini P; Spezia E; Todeschini A; Iughetti L
Ital J Pediatr; 2022 Jul; 48(1):128. PubMed ID: 35897042
[TBL] [Abstract][Full Text] [Related]
18. Adult-onset leukoencephalopathy with vanishing white matter with compound heterozygous EIF2B3 gene variants.
Gui M; He M; Qin L
BMC Neurol; 2024 Jun; 24(1):201. PubMed ID: 38872124
[TBL] [Abstract][Full Text] [Related]
19. Vanishing white matter disease with a novel EIF2B5 mutation: A 10-year follow-up.
Bektaş G; Yeşil G; Özkan MU; Yıldız EP; Uzunhan TA; Çalışkan M
Clin Neurol Neurosurg; 2018 Aug; 171():190-193. PubMed ID: 29933199
[TBL] [Abstract][Full Text] [Related]
20. Vanishing white matter disease caused by EIF2B2 mutation with the presentation of an adrenoleukodystrophy phenotype.
Alsalem A; Shaheen R; Alkuraya FS
Gene; 2012 Apr; 496(2):141-3. PubMed ID: 22285377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
